In addition, the results from several preclinical studies indicate that VEGFA inhibition or treatment with anti-VEGFA antibodies blocks the growth of human prostate tumors through suppression of angiogenesis [21,22,48], further supporting the role of VEGFA-mediated angiogenesis in PCa growth and progression. Here, VEGFA is linked to posterior cortical atrophy.